Literature DB >> 33516183

Assessment of syndromic management of curable sexually transmitted and reproductive tract infections among pregnant women: an observational cross-sectional study.

Enesia Banda Chaponda1, Jane Bruce2, Charles Michelo3,4, Daniel Chandramohan2, R Matthew Chico2.   

Abstract

BACKGROUND: This study estimated the prevalence of curable sexually transmitted and reproductive tract infections (STIs/RTIs) among pregnant women attending antenatal care (ANC) in rural Zambia, evaluated the effectiveness of syndromic management of STIs/RTIs versus reference-standard laboratory diagnoses, and identified determinants of curable STIs/RTIs during pregnancy.
METHODS: A total of 1086 pregnant women were enrolled at ANC booking, socio-demographic information and biological samples were collected, and the provision of syndromic management based care was documented. The Piot-Fransen model was used to evaluate the effectiveness of syndromic management versus etiological testing, and univariate and multivariate logistic regression analyses were used to identify determinants of STIs/RTIs.
RESULTS: Participants had a mean age of 25.6 years and a mean gestational age of 22.0 weeks. Of 1084 women, 700 had at least one STI/RTI (64.6%; 95% confidence interval [CI], 61.7, 67.4). Only 10.2% of infected women received any treatment for a curable STI/RTI (excluding syphilis). Treatment was given to 0 of 56 women with chlamydia (prevalence 5.2%; 95% CI, 4.0, 6.6), 14.7% of participants with gonorrhoea (prevalence 3.1%; 95% CI, 2.2, 4.4), 7.8% of trichomoniasis positives (prevalence 24.8%; 95% CI, 22.3, 27.5) and 7.5% of women with bacterial vaginosis (prevalence 48.7%; 95% CI, 45.2, 51.2). An estimated 7.1% (95% CI, 5.6, 8.7) of participants had syphilis and received treatment. Women < 20 years old were more likely (adjusted odds ratio [aOR] = 5.01; 95% CI: 1.23, 19.44) to have gonorrhoea compared to women ≥30. The odds of trichomoniasis infection were highest among primigravidae (aOR = 2.40; 95% CI: 1.69, 3.40), decreasing with each subsequent pregnancy. Women 20 to 29 years old were more likely to be diagnosed with bacterial vaginosis compared to women ≥30 (aOR = 1.58; 95% CI: 1.19, 2.10). Women aged 20 to 29 and ≥ 30 years had higher odds of infection with syphilis, aOR = 3.96; 95% CI: 1.40, 11.20 and aOR = 3.29; 95% CI: 1.11, 9.74 respectively, compared to women under 20.
CONCLUSIONS: Curable STIs/RTIs were common and the majority of cases were undetected and untreated. Alternative approaches are urgently needed in the ANC setting in rural Zambia.

Entities:  

Keywords:  Bacterial vaginosis; Prevalence; Reproductive tract infections; Risk factors; Sexually transmitted infections; Sub-Saharan Africa; Syndromic management

Year:  2021        PMID: 33516183      PMCID: PMC7847014          DOI: 10.1186/s12884-021-03573-3

Source DB:  PubMed          Journal:  BMC Pregnancy Childbirth        ISSN: 1471-2393            Impact factor:   3.007


  24 in total

1.  Maternal gonococcal infection as a preventable risk factor for low birth weight.

Authors:  B Elliott; R C Brunham; M Laga; P Piot; J O Ndinya-Achola; G Maitha; M Cheang; F A Plummer
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

2.  Chlamydia and Gonorrhea in HIV-Infected Pregnant Women and Infant HIV Transmission.

Authors:  Kristina Adachi; Jeffrey D Klausner; Claire C Bristow; Jiahong Xu; Bonnie Ank; Mariza G Morgado; D Heather Watts; Fred Weir; David Persing; Lynne M Mofenson; Valdilea G Veloso; Jose Henrique Pilotto; Esau Joao; Karin Nielsen-Saines
Journal:  Sex Transm Dis       Date:  2015-10       Impact factor: 2.830

3.  HIV acquisition during pregnancy and postpartum is associated with genital infections and partnership characteristics.

Authors:  John Kinuthia; Alison L Drake; Daniel Matemo; Barbra A Richardson; Clement Zeh; Lusi Osborn; Julie Overbaugh; R Scott McClelland; Grace John-Stewart
Journal:  AIDS       Date:  2015-09-24       Impact factor: 4.177

4.  The effectiveness of a syndromic approach in managing vaginal infections among pregnant women in northern Tanzania.

Authors:  S E Msuya; J Uriyo; B Stray-Pedersen; N E Sam; E M Mbizvo
Journal:  East Afr J Public Health       Date:  2009-12

5.  Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcome of pregnancy.

Authors:  Deborah Watson-Jones; John Changalucha; Balthazar Gumodoka; Helen Weiss; Mary Rusizoka; Leonard Ndeki; Anne Whitehouse; Rebecca Balira; James Todd; Donatila Ngeleja; David Ross; Anne Buvé; Richard Hayes; David Mabey
Journal:  J Infect Dis       Date:  2002-09-03       Impact factor: 5.226

6.  Malarial Infection and Curable Sexually Transmitted and Reproductive Tract Infections Among Pregnant Women in a Rural District of Zambia.

Authors:  Enesia Banda Chaponda; R Matthew Chico; Jane Bruce; Charles Michelo; Bellington Vwalika; Sungano Mharakurwa; Mike Chaponda; James Chipeta; Daniel Chandramohan
Journal:  Am J Trop Med Hyg       Date:  2016-09-26       Impact factor: 2.345

7.  Syphilis in pregnant women in Zambia.

Authors:  A V Ratnam; S N Din; S K Hira; G J Bhat; D S Wacha; A Rukmini; R C Mulenga
Journal:  Br J Vener Dis       Date:  1982-12

8.  High burden of malaria infection in pregnant women in a rural district of Zambia: a cross-sectional study.

Authors:  Enesia Banda Chaponda; Daniel Chandramohan; Charles Michelo; Sungano Mharakurwa; James Chipeta; R Matthew Chico
Journal:  Malar J       Date:  2015-09-30       Impact factor: 2.979

9.  Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors.

Authors:  K Baisley; J Changalucha; H A Weiss; K Mugeye; D Everett; I Hambleton; P Hay; D Ross; C Tanton; T Chirwa; R Hayes; D Watson-Jones
Journal:  Sex Transm Infect       Date:  2009-05-26       Impact factor: 3.519

Review 10.  On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections.

Authors:  R Matthew Chico; Berkin B Hack; Melanie J Newport; Enesia Ngulube; Daniel Chandramohan
Journal:  Expert Rev Anti Infect Ther       Date:  2013-11-06       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.